Suchergebnisse - "Saxena, Kunal"

PubPharm (5)

1

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US

enthalten in: Human vaccines & immunotherapeutics | 2023

von Saxena, K. | Kathe, N. | Sardana, P. | +3

2

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

enthalten in: Human vaccines & immunotherapeutics | 2023

von Cheung, T. | Cheng, S. | Hsu, D. | +4

3

Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway : incorporating the full health impact of all HPV-related diseases

enthalten in: Journal of medical economics | 2023

von Diakite, I. | Nguyen, S. | Sabale, U. | +5

4

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

enthalten in: Cost effectiveness and resource allocation : C/E | 2021

von Cheung, T. | Cheng, S. | Hsu, D. | +5

5

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

enthalten in: Cost effectiveness and resource allocation | 2021

von Cheung, T. | Cheng, S. | Hsu, D. | +5

1
[1]